These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27910990)
1. A pH-responsive sequential-disassembly nanohybrid for mitochondrial targeting. Li L; Sun W; Li L; Liu Y; Wu L; Wang F; Zhou Z; Zhang Z; Huang Y Nanoscale; 2017 Jan; 9(1):314-325. PubMed ID: 27910990 [TBL] [Abstract][Full Text] [Related]
2. Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo. Zhang J; Yang C; Pan S; Shi M; Li J; Hu H; Qiao M; Chen D; Zhao X Drug Deliv; 2018 Nov; 25(1):723-737. PubMed ID: 29513049 [TBL] [Abstract][Full Text] [Related]
3. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304 [TBL] [Abstract][Full Text] [Related]
4. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle. Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547 [TBL] [Abstract][Full Text] [Related]
5. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo. Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495 [TBL] [Abstract][Full Text] [Related]
6. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy. Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494 [TBL] [Abstract][Full Text] [Related]
7. pH-Responsive Core-Shell Structured Nanoparticles for Triple-Stage Targeted Delivery of Doxorubicin to Tumors. Han L; Tang C; Yin C ACS Appl Mater Interfaces; 2016 Sep; 8(36):23498-508. PubMed ID: 27558413 [TBL] [Abstract][Full Text] [Related]
8. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA. Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085 [TBL] [Abstract][Full Text] [Related]
9. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency. Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268 [TBL] [Abstract][Full Text] [Related]
10. Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting. Li L; Sun W; Zhang Z; Huang Y J Control Release; 2016 Jun; 232():62-74. PubMed ID: 27098443 [TBL] [Abstract][Full Text] [Related]
11. Dual Stimuli-Responsive Hybrid Polymeric Nanoparticles Self-Assembled from POSS-Based Starlike Copolymer-Drug Conjugates for Efficient Intracellular Delivery of Hydrophobic Drugs. Yang Q; Li L; Sun W; Zhou Z; Huang Y ACS Appl Mater Interfaces; 2016 Jun; 8(21):13251-61. PubMed ID: 27167898 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Li L; Yang Q; Zhou Z; Zhong J; Huang Y Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960 [TBL] [Abstract][Full Text] [Related]
13. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA. Han L; Tang C; Yin C Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552 [TBL] [Abstract][Full Text] [Related]
14. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery. Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830 [TBL] [Abstract][Full Text] [Related]
15. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
16. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery. Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291 [TBL] [Abstract][Full Text] [Related]
17. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952 [TBL] [Abstract][Full Text] [Related]
18. Engineering of Biocompatible pH-Responsive Nanovehicles from Acetalated Cyclodextrins as Effective Delivery Systems for Tumor Therapy. Zhang D; Wei Y; Chen K; Gong H; Han S; Guo J; Li X; Zhang J J Biomed Nanotechnol; 2015 Jun; 11(6):923-41. PubMed ID: 26353583 [TBL] [Abstract][Full Text] [Related]
19. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo. Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843 [TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester. Jäger E; Jäger A; Chytil P; Etrych T; Ríhová B; Giacomelli FC; Stěpánek P; Ulbrich K J Control Release; 2013 Jan; 165(2):153-61. PubMed ID: 23178950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]